Drug Evaluation Committee Questionnaire Report on OSS Usage in FY2024
Data Science Subcommittee
January 2025
We have compiled the results of a survey on the use of open source software (OSS), "R", in clinical development work among the member companies of the Data Science Committee and its discussion in the "FY2024 OSS Usage Questionnaire Report".
The results of the survey show the current status of how "R" is being used in clinical development work, changes from a similar survey conducted two years ago, and what each company expects and considers to be issues.
We hope that this report will help you consider the use of open source software, especially R, in your company.
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee
Data Science Subcommittee FY2024 Ongoing Task Force 11